Statistical Methods for Analyzing Immunosignatures
Author Information
Author(s): Justin R. Brown, Phillip Stafford, Stephen A. Johnston, Valentin Dinu
Primary Institution: Arizona State University
Hypothesis
How best to analyze and decode the information from immunosignaturing studies?
Conclusion
Immunosignaturing is a promising technology for screening and presymptomatic detection of disease.
Supporting Evidence
- Immunosignaturing can classify samples based on disease status.
- Statistical methods used showed significant results in differentiating disease states.
- Latent factors identified may serve as biomarkers for disease.
Takeaway
This study looks at a new way to understand how our immune system responds to diseases, which could help doctors find diseases earlier.
Methodology
The study used various statistical methods including exploratory and confirmatory factor analyses, classical significance testing, and structural equation modeling to analyze immunosignatures from patient samples.
Potential Biases
Potential biases may arise from the non-matching of normal samples to cancer groups.
Limitations
The study faced challenges due to the complexity of immunosignaturing microarrays and the lack of a well-curated control group.
Participant Demographics
All samples were from females aged 45 to 54.
Statistical Information
P-Value
1.4372E-09
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website